Stockreport

Magenta Therapeutics Presents New Preclinical Data on MGTA-145 Stem Cell Mobilization Product Candidate

Magenta Therapeutics, Inc.  (MGTA) 
Last magenta therapeutics, inc. earnings: 11/13 08:00 am Check Earnings Report
PDF A single dose of MGTA-145 mobilized large numbers of hematopoietic stem cells in hours that engrafted robustly in primates MGTA-1 [Read more]